Riskpilot← Back to searchSign inGet full accessDoaMed AB
ABActiveOrg 5591774335Ryttartorpsvägen 11Hospital activities · NACE 8610Est. 20181-4 employees
Revenue 2025
SEK 467K
+51% vs 2024
EBITDA margin
71.5%
+71% vs 2024
Equity ratio
56.5%
Financial strength
Net profit 2025
SEK 213K
+322% vs 2024
| Revenue | SEK 467K | +51% |
| EBITDA | SEK 334K | +71% |
| Net profit | SEK 213K | +322% |
| Total assets | SEK 2,3M | -4% |
| Equity | SEK 1,3M | +19% |
| Employees | — | — |
Legal name
DoaMed AB
Org number
5591774335
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
30 oktober 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget erbjuder läkarbemanning till primärvårdsmottagningar samt till medicinkliniker och akutmottagningar. Mitt företag vänder sig till Större bemanningsföretag inom hälsosjukvård branschen samt vårdcentraler och sjukhus som är i behov av läkare. Allmän och specialistläkarbemanning. Tillgänglighet, precision, högkompetens och god kvalité. Vi täcker behovet i ett sort och brett kompetensområde för både allmänläkare och specialistläkarbemanning.
Address
Ryttartorpsvägen 11
Email
ehabkhaterman@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 142 | 267 | 357 | 309 | 467 |
| Staff expenses | — | — | — | −52 | −69 |
| EBITDA | 120 | 217 | 295 | 195 | 334 |
| Depreciation & amort. | −0 | — | — | −44 | −52 |
| EBIT | 120 | 217 | 295 | 151 | 282 |
| Net financials | −222 | 376 | 145 | −18 | 10 |
| Profit before tax | 258 | 592 | 439 | 68 | 271 |
| Tax | −55 | −39 | −16 | −18 | −58 |
| Net profit | 203 | 553 | 423 | 51 | 213 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 164 | 2 359 | 2 294 | 2 431 | 2 346 |
| Equity | 256 | 809 | 1 062 | 1 113 | 1 326 |
| Long-term debt | 1 002 | 1 058 | 733 | 706 | 597 |
| Short-term debt | 906 | 492 | 499 | 548 | 338 |
| Total debt | 1 908 | 1 550 | 1 232 | 1 254 | 935 |
EBITDA margin
71.5%
This company
15.8%
Market median
+353% vs market
20212025
Equity ratio
56.5%
This company
38.2%
Market median
+48% vs market
20212025
Return on equity
16.1%
This company
18.4%
Market median
+12% vs market
20212025
Net profit margin
45.6%
This company
8.1%
Market median
+463% vs market
20212025
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20212025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DoaMed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ihab Khater | Board of Directors | 0 companies |
| Doaa Hassan | Deputy Board Member | 0 companies |